跳至主要内容
临床试验/CTRI/2025/12/098484
CTRI/2025/12/098484尚未招募4 期

Blinded Randomized Controlled Trial of rTMS to the Dorsolateral Prefrontal Cortex in Progressive Supranuclear Palsy: Effects on Gait, Cognition, and Brain Perfusion

Citi Neuro Centre Foundation1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年12月15日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
100
试验地点
1
主要终点
Gait: Change in Time taken to walk 10 meters measured via video gait recording of Timed up and go test (TUG)

研究概览

简要总结

Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive brain stimulation technique shown to be useful in treating a number of neuropsychiatric conditions including depression, neuropathic pain and Parkinson’s disease (PD). While in depression, rTMS is being increasingly used, its use in Parkinsonian syndromes has been impeded by lack of high-quality evidence. A few studies have explored rTMS in PD and atypical Parkinsonian syndromes such as Progressive supranuclear palsy (PSP). However, most studies are limited by small samples, inadequate dosage of intervention and lack of patho-physiological study correlates.

The use of rTMS in depression has gained widespread attention and acceptance. The runaway success of rTMS in major depressive disorder (MDD) is rooted in a firm biological basis with the dorsolateral prefrontal cortex (DLPFC) at its heart. In MDD, the left DLPFC is hypoactive and right DLPFC is hyperactive. Therefore, logic dictates that improvement in activity of left DLPFC or inhibition of right DLPFC activity would be able to reverse depression. rTMS is capable of neuro stimulation at high frequency and inhibition at low frequency. Taken together, rTMS is a convenient non-invasive tool that has tremendous potential to modulate neural circuits in depression and this has been applied by multiple researchers.

DLPFC, especially the left DLPFC, is a large specialized area of the prefrontal cortex with a significant role in maintaining working memory. Working memory is the ability to hold information online for a few seconds to minutes. This is essential to keep track of ongoing activity, the components of activity that have been executed and the pending components that have to be executed in order to complete a task. Working memory research has been predominantly focused on specific sensory modalities such as visuospatial (visual) working memory or phonological (verbal) working memory. Recent research has shown evidence to suggest existence of motor working memory along similar lines. Deficits in working memory have been shown to be associated with increased falls in elderly. This is an important realization as interventions improving cognition may improve falls and gait.

In general, older adults demonstrate relative hyperactivity of brain during a given task when compared to younger individuals. This is thought to be a compensatory phenomenon as older brains recruit additional brain regions to compensate for age related degeneration. The left DLPFC plays an important role in gait. In elderly, there is a relative hyperactivity of left DLPFC during walking. By corollary, dysfunction of DLPFC can therefore lead to abnormalities in walking and gait, and by extension can lead to increased risk of falls.

In PSP, there is evidence to suggest dysfunction of left DLPFC. A recent study evaluated the effects of transcranial direct current stimulation (tDCS) over left DLPFC in PSP and found it to be ineffective in improving cognitive and motor functions. However, the study was severely limited with only 16 subjects receiving real tDCS for only 5 days per week for 2 weeks. While there have been rTMS studies on gait in PSP, none of them evaluated DLPFC stimulation. Both these studies were limited by small sample size and limited rTMS dosage. Therefore, a sufficiently powered study with appropriate sample size and appropriate rTMS dosage on DLPFC in PSP is lacking. This study aims to assess the efficacy of DLPFC rTMS in improving gait and cognition, and to evaluate associated changes in cerebral perfusion using arterial spin labeling (ASL) MRI in PSP patients.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant, Investigator and Outcome Assessor Blinded

入排标准

年龄范围
40.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Diagnosis of PSP according to MDS criteria -Ability to stand unassisted for 30 seconds and able to walk independently -MMSE 18 or more -On stable treatment of anticholinergic, dopaminergic, serotonergic or NMDA antagonist medication -Age 40–80 years -Able to undergo MRI and rTMS -Informed consent provided.

排除标准

  • Contraindications to rTMS or MRI (e.g., metallic implants) -Pregnancy -History of cerebellar ataxia, SOL, hydrocephalus, SDH, Prior vestibular disease -Sensory deficit in feet -Epilepsy.

结局指标

主要结局

Gait: Change in Time taken to walk 10 meters measured via video gait recording of Timed up and go test (TUG)

时间窗: 2 months, 3 months, 4 months and 6 months

Cognition: Changes in Montreal Cognitive Assessment (MoCA) and Frontal assessment battery (FAB) scores

时间窗: 2 months, 3 months, 4 months and 6 months

次要结局

  • -Change in number of Falls with falls diary(-Change in PSP rating scale)

研究者

发起方
Citi Neuro Centre Foundation
申办方类型
Private hospital/clinic
责任方
Principal Investigator
主要研究者

Dr Yaranagula Sai Deepak

Citi Neuro Centre

研究点 (1)

Loading locations...

相似试验